Transferrin and cell-penetrating peptide dual-functioned liposome for targeted drug delivery to glioma

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 2, 2015, Pages 1658-1668

  Zheng, Chuanyi ^a,b   Ma, Chunyang ^b   Bai, Enqi ^b   Yang, Kun ^b   Xu, Ruxiang ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b HAINAN MEDICAL UNIVERSITY   (China)

Author keywords

Blood brain barrier; Cell penetrating peptide; Dual ligand; Liposome; Transferrin receptor

Indexed keywords

CELL PENETRATING PEPTIDE; DOXORUBICIN; LIPOSOME; TRANSACTIVATING TRANSCRIPTIONAL ACTIVATOR PEPTIDE; TRANSACTIVATOR PROTEIN; TRANSFERRIN; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY ENDOTHELIAL CELL; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG TARGETING; GLIOMA; GLIOMA CELL LINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MOUSE; MTT ASSAY; NONHUMAN; PHYSICAL CHEMISTRY; SURVIVAL TIME;

RATTUS;

EID: 84926304241     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. [1] Qin Y, Chen H, Yuan W, Kuai R, Zhang Q, Xie F, Zhang L, Zhang Z, Liu J, He Q. Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery. Int J Pharm 2011; 419: 85-95.
2. [2] Behin A, Hoang-Xuan K, Carpentier AF and Delattre JY. Primary brain tumors in adults. Lancet 2003; 361: 323-331.
3. [3] Gan CW and Feng SS. Transferrin-conjugated nanoparticles of Poly (lactide)-D-a –Tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier. Biomaterials 2010; 31: 7748-7757.
4. [4] Chen Y and Liu L. Modern methods for delivery of drugs across the blood-brain barrier. Adv Drug Deliv Rev 2012; 64: 640-665.
5. [5] Gao H, Yang Z, Cao S, Xiong Y, Zhang S, Pang Z, Jiang X. Tumor cells and neo-vasculature dual targeting delivery for glioblastoma treatment. Biomaterials 2014; 35: 2374-2382.
6. [6] Lu W, Xiong C, Zhang R, Shi L, Huang M, Zhang G, Song S, Huang Q, Liu GY, Li C. Receptor-mediated transcytosis: a mechanism for active extravascular transport of nanoparticles in solid tumors. J Control Release 2012; 161: 959-966.
7. [7] Gao H, Yang Z, Zhang S, Cao S, Pang Z, Yang X, Jiang X. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth. J Control Release 2013; 172: 921-928.
8. [8] Gao H, Qian J, Cao S, Yang Z, Pang Z, Pan S, Fan L, Xi Z, Jiang X, Zhang Q. Precise glioma targeting of and penetration by aptamer andpeptide dual-functioned nanoparticles. Bio-materials 2012; 33: 5115-5123.
9. [9] Beduneau A, Saulnier P, Benoit JP. Active targeting of brain tumors using nanocarriers. Biomaterials 2007; 28: 4947-4967.
10. [10] Huile G, Shuaiqi P, Zhi Y, Shijie C, Chen C, Xinguo J, Shun S, Zhiqing P, Yu H. A cascade targeting strategy for brain neuroglial cells employing nanoparticles modified with angiopep-2 peptide and EGFP-EGF1 protein. Biomaterials 2011; 32: 8669-8675.
11. [11] Qin Y, Chen H, Zhang Q, Wang X, Yuan W, Kuai R, Tang J, Zhang L, Zhang Z, Zhang Q, Liu J, He Q. Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals. Int J Pharm 2011; 420: 304-312.
12. [12] Kuai R, Yuan W, Qin Y, Chen H, Tang J, Yuan M, Zhang Z, He Q. Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes. Mol Pharm 2010; 7: 1816-1826.
13. [13] Bidros DS and Vogelbaum MA. Novel drug delivery strategies in neuro-oncology. Neurotherapeutics 2009; 3: 539-546.
14. [14] Gao JQ, Lv Q, Li LM, Tang XJ, Li FZ, Hu YL, Han M. Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes. Biomaterials 2013; 34: 5628-5639.
15. [15] Miyata S, Kawabata S, Hiramatsu R, Doi A, Ikeda N, Yamashita T, Kuroiwa T, Kasaoka S, Maruyama K, Miyatake S. Computed tomography imaging of transferrin targeting liposomes encapsulating both boron and iodine contrast agents by convection-enhanced delivery to F98 rat glioma for boron neutron capture therapy. Neurosurgery 2011; 68: 1380-1387.
16. [16] Ying X, Wen H, Lu WL, Du J, Guo J, Tian W, Men Y, Zhang Y, Li RJ, Yang TY, Shang DW, Lou JN, Zhang LR, Zhang Q. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. J Control Release 2010; 141: 183-192.
17. [17] Banks WA, Robinson SM, Nath A. Permeability of the blood–brain barrier to HIV-1 TAT. Exp Neurol 2005; 193: 218-227.
18. [18] Brooks H, Lebleu B, Vivès E. Tat peptide-mediated cellular delivery: back to basics. Adv Drug Deliv Rev 2005; 57: 559-577.
19. [19] Torchilin VP, Rammohan R, Weissig V, Levchenko TS. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci U S A 2001; 98: 8786-8791.
20. [20] Kuai R, Yuan W, Li W, Qin Y, Tang J, Yuan M, Fu L, Ran R, Zhang Z, He Q. Targeted Delivery of Cargoes into a Murine Solid Tumor by a Cell-Penetrating Peptide and Cleavable Poly (ethylene glycol) Comodified Liposomal Delivery System via Systemic Administration. Mol Pharm 2011; 8: 2151-2161.
21. [21] Maeda T and Fujimoto K. A reduction-triggered delivery by a liposomal carrier possessing membrane-permeable ligands and a detachable coating. Colloids Surf B Biointerfaces 2006; 49: 15-21.
22. [22] Song S, Liu D, Peng J, Sun Y, Li Z, Gu JR, Xu Y. Peptide ligand-mediated liposome distribution and targeting to EGFR expressing tumor in vivo. Int J Pharm 2008; 363: 155-161.
23. [23] Chiu SJ, Liu S, Perrotti D, Marcucci G and Lee RJ. Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomes. J Control Release 2006; 112: 199-207.
24. [24] Brown RC, Morris AP and O’Neil RG. Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells. Brain Res 2007; 1130: 17-30.
25. [25] Simon MJ, Kang WH, Gao S, Banta S, Morrison B 3rd. Increased delivery of TAT across an endothelial monolayer following ischemic injury. Neurosci Lett 2010; 486: 1-4.
26. [26] Biswas S, Deshpande PP, Perche F, Dodwadkar NS, Sane SD, Torchilin VP. Octaarginine-modified pegylated liposomal doxorubicin: an effective treatment strategy for non-small cell lung cancer. Cancer Lett 2013; 335: 191-200.
27. [27] Yin Y, Wu X, Yang Z, Zhao J, Wang X, Zhang Q, Yuan M, Xie L, Liu H, He Q. The potential efficacy of R8-modified paclitaxel-loaded liposomes on pulmonary arterial hypertension. Pharm Res 2013; 30: 2050-2062.
28. [28] Du W, Fan Y, Zheng N, He B, Yuan L, Zhang H, Wang X, Wang J, Zhang X, Zhang Q. Transferrin receptor specific nanocarriers conjugated with functional 7peptide for oral drug delivery. Biomaterials 2013; 34: 794-806.
29. [29] Wender PA, Galliher WC, Goun EA, Jones LR, Pillow TH. The design of guanidinium-rich transporters and their internalization mechanisms. Adv Drug Deliv Rev 2008; 60: 452-472.